VEGFR2 signalling contributes to increased endothelial susceptibility to TNF-α under chronic non-uniform shear stress

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 499-509

  Urschel, Katharina ^a   Garlichs, Christoph D ^a   Daniel, Werner G ^a   Cicha, Iwona ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Endothelial cells; Mechanotransduction; Monocyte adhesion; Non uniform shear stress; VEGFR2

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; RECEPTOR ANTIBODY; RECEPTOR BLOCKING AGENT; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 2; ZM 323881;

ARTICLE; CELL ADHESION; CELL ASSAY; CELL NUCLEUS; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTRACELLULAR SIGNALING; MONOCYTE; PHYSICAL SENSITIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; RNA INTERFERENCE; SHEAR STRESS; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; BLOTTING, WESTERN; CELL ADHESION; CELLS, CULTURED; CHROMONES; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; E-SELECTIN; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; MECHANOTRANSDUCTION, CELLULAR; MONOCYTES; MORPHOLINES; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN KINASE INHIBITORS; PYRIMIDINES; QUINAZOLINES; RNA INTERFERENCE; SRC-FAMILY KINASES; STRESS, MECHANICAL; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 82955203168     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.09.045     Document Type: Article

References (32)

1. Li Y.S., Haga J.H., Chien S. Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomech 2005, 38:1949-1971.
2. Wasserman S.M., Mehraban F., Komuves L.G., Yang R.B., Tomlinson J.E., Zhang Y., et al. Gene expression profile of human endothelial cells exposed to sustained fluid shear stress. Physiol Genomics 2002, 12:13-23.
3. Slager C.J., Wentzel J.J., Gijsen F.J., Schuurbiers J.C., van der Wal A.C., van der Steen A.F., et al. The role of shear stress in the generation of rupture-prone vulnerable plaques. Nat Clin Pract Cardiovasc Med 2005, 2:401-407.
4. Cicha I., Beronov K., Ramirez E.L., Osterode K., Goppelt-Struebe M., Raaz D., et al. Shear stress preconditioning modulates endothelial susceptibility to circulating TNF-alpha and monocytic cell recruitment in a simplified model of arterial bifurcations. Atherosclerosis 2009, 207:93-102.
5. Pan S. Molecular mechanisms responsible for the atheroprotective effects of laminar shear stress. Antioxid Redox Signal 2009, 11:1669-1682.
6. Tzima E., Irani-Tehrani M., Kiosses W.B., Dejana E., Schultz D.A., Engelhardt B., et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 2005, 437:426-431.
7. Wang Y., Flores L., Lu S., Miao H., Li Y.S., Chien S. Shear stress regulates the Flk-1/Cbl/PI3K/NF-kappa B pathway via actin and tyrosine kinases. Cell Mol Bioeng 2009, 2:341-350.
8. Harry B.L., Sanders J.M., Feaver R.E., Lansey M., Deem T.L., Zarbock A., et al. Endothelial cell PECAM-1 promotes atherosclerotic lesions in areas of disturbed flow in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2008, 28:2003-2008.
9. Chen Z., Tzima E. PECAM-1 is necessary for flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol 2009, 29:1067-1073.
10. Holmes K., Roberts O.L., Thomas A.M., Cross M.J. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007, 19:2003-2012.
11. Facemire C.S., Nixon A.B., Griffiths R., Hurwitz H., Coffman T.M. Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. Hypertension 2009, 54:652-658.
12. Gee E., Milkiewicz M., Haas T.L. p38 MAPK activity is stimulated by vascular endothelial growth factor receptor 2 activation and is essential for shear stress-induced angiogenesis. J Cell Physiol 2010, 222:120-126.
13. Wang Y., Chang J., Chen K.D., Li S., Li J.Y., Wu C., et al. Selective adapter recruitment and differential signaling networks by VEGF vs. shear stress. Proc Natl Acad Sci U S A 2007, 104:8875-8879.
14. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 376:62-66.
15. Cicha I., Goppelt-Struebe M., Muehlich S., Yilmaz A., Raaz D., Daniel W.G., et al. Pharmacological inhibition of RhoA signaling prevents connective tissue growth factor induction in endothelial cells exposed to non-uniform shear stress. Atherosclerosis 2008, 196:136-145.
16. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003, 10:45-65.
17. VandenBerg E., Reid M.D., Edwards J.D., Davis H.W. The role of the cytoskeleton in cellular adhesion molecule expression in tumor necrosis factor-stimulated endothelial cells. J Cell Biochem 2004, 91:926-937.
18. Stefanadis C., Toutouzas K., Stefanadi E., Lazaris A., Patsouris E., Kipshidze N. Inhibition of plaque neovascularization and intimal hyperplasia by specific targeting vascular endothelial growth factor with bevacizumab-eluting stent: an experimental study. Atherosclerosis 2007, 195:269-276.
19. Chen K.D., Li Y.S., Kim M., Li S., Yuan S., Chien S., et al. Mechanotransduction in response to shear stress. Roles of receptor tyrosine kinases, integrins, and shc. J Biol Chem 1999, 274:18393-18400.
20. Wang Y., Miao H., Li S., Chen K.D., Li Y.S., Yuan S., et al. Interplay between integrins and FLK-1 in shear stress-induced signaling. Am J Physiol Cell Physiol 2002, 283:C1540-C1547.
21. Bhullar I.S., Li Y.S., Miao H., Zandi E., Kim M., Shyy J.Y., et al. Fluid shear stress activation of I kappa B kinase is integrin-dependent. J Biol Chem 1998, 273:30544-30549.
22. Partridge J., Carlsen H., Enesa K., Chaudhury H., Zakkar M., Luong L., et al. Laminar shear stress acts as a switch to regulate divergent functions of NF-kappa B in endothelial cells. FASEB J 2007, 21:3553-3561.
23. Kim I., Moon S.O., Kim S.H., Kim H.J., Koh Y.S., Koh G.Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 2001, 276:7614-7620.
24. Wang Y., Chang J., Li Y.C., Li Y.S., Shyy J.Y., Chien S. Shear stress and VEGF activate IKK via the Flk-1/Cbl/Akt signaling pathway. Am J Physiol Heart Circ Physiol 2004, 286:H685-H692.
25. Jin Z.G., Ueba H., Tanimoto T., Lungu A.O., Frame M.D., Berk B.C. Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circ Res 2003, 93:354-363.
26. Dayanir V., Meyer R.D., Lashkari K., Rahimi N. Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J Biol Chem 2001, 276:17686-17692.
27. Liu J., Agarwal S. Mechanical signals activate vascular endothelial growth factor receptor-2 to upregulate endothelial cell proliferation during inflammation. J Immunol 2010, 185:1215-1221.
28. Thomas S.M., Brugge J.S. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997, 13:513-609.
29. Yogi A., O'Connor S.E., Callera G.E., Tostes R.C., Touyz R.M. Receptor and nonreceptor tyrosine kinases in vascular biology of hypertension. Curr Opin Nephrol Hypertens 2010, 19:169-176.
30. Hauer A.D., van Puijvelde G.H., Peterse N., de Vos P., van Weel V., van Wanrooij E.J., et al. Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:2050-2057.
31. Petrovan R.J., Kaplan C.D., Reisfeld R.A., Curtiss L.K. DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2007, 27:1095-1100.
32. Vaklavas C., Lenihan D., Kurzrock R., Tsimberidou A.M. Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target?. Oncologist 2010, 15:130-141.